Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications.

@article{Straker2005CosteffectiveSF,
  title={Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications.},
  author={David Straker and Christoph U Correll and Elisse Kramer-Ginsberg and N. A. Abdulhamid and Fiju Koshy and Elayna O. Rubens and Robert Saint-Vil and John M. Kane and Peter Manu},
  journal={The American journal of psychiatry},
  year={2005},
  volume={162 6},
  pages={
          1217-21
        }
}
OBJECTIVE Despite concerns about the adverse effects of second-generation antipsychotics on weight regulation and glucose and lipid metabolism, little is known about the relationship between these agents and the metabolic syndrome. Because the metabolic syndrome is more strongly associated with cardiovascular morbidity and mortality than its individual components, attention to the full syndrome is important. The authors' goal was to explore the relationship between second-generation… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 35 CITATIONS

Systematic screening for metabolic syndrome in consumers with severe mental illness.

  • International journal of mental health nursing
  • 2009
VIEW 2 EXCERPTS
HIGHLY INFLUENCED